Company: HSDTW
Filing Date: 2025-03-14
Form Type: PRE 14A
Source: 0001558370-25-003007
Chunk: 70

Company: Solana Co
Filing Date: 2025-03-14
Form: PRE 14A
Chunk 70
---
 to the date of the 2026 annual meeting or the 10th day following the day on which public announcement is made of the date of the 2026 annual meeting, and (ii) not earlier than the 120th day prior to the 2026 annual meeting.

The above-mentioned proposals and notice to the Corporate Secretary must also be in compliance with the Bylaws (including the information requirements therein) and the proxy solicitation rules of the SEC and Nasdaq as applicable. As such, stockholders who intend to solicit proxies in support of director nominees other than the Company’s nominees must comply with the additional requirements of Rule 14a-19 under the Exchange Act including providing notice that sets forth the information required by not earlier than the close of business on December 22, 2025 and not later than the close of business on January 21, 2026. We reserve the right to reject, rule out of order or take other appropriate action with respect to any proposal that does not comply with the foregoing and other applicable requirements.

#### Solicitation by Board; Expenses
The Board is sending you this proxy statement in connection with the solicitation of proxies for use at the Annual Meeting. The Company’s directors, officers and regular employees may solicit proxies personally, telephonically, electronically or by other means of communication, but they will not receive any additional compensation for these services. The Company will pay the cost of preparing, assembling, and mailing the proxy materials. The Company has requested brokers, banks and other nominees to send the proxy materials to, and to obtain proxies from, the beneficial owners and the Company will reimburse such record holders for their reasonable expenses in doing so.

**Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be Held on April 21, 2025**

The proxy statement, proxy card and annual report to stockholders are available at www.proxyvote.com.

<div align='center'>42</div>

#### Your cooperation in giving this matter your immediate attention and in voting your proxies promptly is appreciated.​By Order of the Board of Directors,​​Jeffrey S. MathiesenChief Financial Officer, Treasurer and SecretaryMarch 25, 2025​​​​​
43

APPENDIX A CERTIFICATE OF AMENDMENT
TO THE
CERTIFICATE OF INCORPORATION
OF
HELIUS MEDICAL TECHNOLOGIES, INC. HELIUS MEDICAL TECHNOLOGIES, INC.(the “ Corporation”), a corporation organized and existing under and by virtue of the General